Effects of feed supplementation with Lactobacillus reuteri and Bacillus subtilis on the liver immunity in largemouth bass (Micropterus salmoides)
Developmental & Comparative Immunology · 2025
DOI: 10.1016/j.dci.2025.105486 ↗Kurz gefasst
Fachartikel in der Zeitschrift Developmental & Comparative Immunology, 2025. Verfasst von Chong Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: University Joint Laboratory of Guangdong Province, Hong Kong and Macao Region on Marine Bioresource Conservation and Exploitation, Guangdong Laborato…. Hauptthemen laut MEDLINE: Bass, Bacillus subtilis, Liver, Probiotics. Die Arbeit nennt 82 Literaturangaben. Gefördert von: Guangzhou Municipal Science and Technology Program key projects, Guangdong Academy of Sciences.
Abstract (Originalsprache)
In the culture of largemouth bass (Micropterus salmoides), probiotics play an important role. Probiotics such as Lactobacillus reuteri and Bacillus subtilis can enhance the immune systems of fish like M. salmoides and help them prevent diseases. The largemouth bass in this experiment were fed a diet containing B. subtilis (BS, 107 CFU/g) and L. reuteri (LR, 107 CFU/g) for 35 days. Investigations were conducted into how the two probiotics affected the liver antioxidant capacity and liver immunity of M. salmoides. The findings revealed that both the BS and LR groups activated the Nrf2/keap1 signaling pathway, significantly increasing the expression of genes such as Nrf2, SOD1, SOD2, GST, and CAT. Moreover, the BS group notably augmented the levels of AKP, T-AOC, SOD, and CAT in the liver. Importantly, the key immune-related pathways enriched for differentially expressed genes in the BS group for hepatic transcriptional machinery encompassed complement and coagulation cascades, IL-17 signaling pathway, and chemokine signaling pathway. In conclusion, B. subtilis and L. reuteri demonstrate the ability to enhance the hepatic antioxidant capacity and immunocompetence of M. salmoides. However, significant differences exist in the intensity of their effects and the types of immune pathways activated in the liver. Both hold promising application value, and this study lays a foundational groundwork for the utilization of B. subtilis and L. reuteri in M. salmoides aquaculture.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University Joint Laboratory of Guangdong Province, Hong Kong and Macao Region on Marine Bioresource Conservation and Exploitation, Guangdong Laboratory for Lingnan Modern Agriculture, College of Marine Sciences, South C…
- Department of Biomedical Sciences and Centre of Reproduction, Development and Aging (CRDA), Faculty of Health Sciences, University of Macau, Taipa, China.
- State Key Laboratory of Applied Microbiology Southern China, Guangdong Provincial Key Laboratory of Microbial Culture Collection and Application, Guangdong Institute of Microbiology, Guangdong Academy of Sciences, Guang…
Förderung
- Guangzhou Municipal Science and Technology Program key projects
- Guangdong Academy of Sciences
Zitieren
APA
Wang, C., Hu, X., Tang, H., Ge, W., Di, L., Zou, J., Zhou, A., & Cui, Z. (2025). Effects of feed supplementation with Lactobacillus reuteri and Bacillus subtilis on the liver immunity in largemouth bass (Micropterus salmoides). Developmental & Comparative Immunology. https://doi.org/10.1016/j.dci.2025.105486
Vancouver
Wang C, Hu X, Tang H, Ge W, Di L, Zou J, et al. Effects of feed supplementation with Lactobacillus reuteri and Bacillus subtilis on the liver immunity in largemouth bass (Micropterus salmoides). Developmental & Comparative Immunology. 2025. doi:10.1016/j.dci.2025.105486
BibTeX
@article{Wang2025,
author = {Wang, Chong and Hu, Xiaodi and Tang, Huijuan and Ge, Wei and Di, Lijun and Zou, Jixing and Zhou, Aiguo and Cui, Zongbin},
title = {Effects of feed supplementation with Lactobacillus reuteri and Bacillus subtilis on the liver immunity in largemouth bass (Micropterus salmoides)},
journal = {Developmental & Comparative Immunology},
year = {2025},
doi = {10.1016/j.dci.2025.105486}
}
EUVIMED